Efficacy News and Research

RSS
Manhattan Scientifics inks exclusive licensing contract with Carpenter Technology

Manhattan Scientifics inks exclusive licensing contract with Carpenter Technology

Provectus' Phase 2 clinical trial of PV-10 for metastatic melanoma complete

Provectus' Phase 2 clinical trial of PV-10 for metastatic melanoma complete

Enzo Biochem and NEI join to conduct a human clinical trial of Enzo’s chronic autoimmune uveitis therapeutic

Enzo Biochem and NEI join to conduct a human clinical trial of Enzo’s chronic autoimmune uveitis therapeutic

Clinical trial results of topical INCB18424 inhibitor announced by Incyte Corporation

Clinical trial results of topical INCB18424 inhibitor announced by Incyte Corporation

Nanoviricides and Southern Research sign agreement to test anti-Influenza and anti-HIV drug candidates

Nanoviricides and Southern Research sign agreement to test anti-Influenza and anti-HIV drug candidates

Blessing Hospital integrates AtStaff’s ClairVia Patient Acuity system with its EMR

Blessing Hospital integrates AtStaff’s ClairVia Patient Acuity system with its EMR

Celsion recommended to continue patient enrollment in its ThermoDox Phase III liver cancer trial

Celsion recommended to continue patient enrollment in its ThermoDox Phase III liver cancer trial

Phase II trial of Impax Pharmaceuticals' Parkinson’s disease drug candidate successful

Phase II trial of Impax Pharmaceuticals' Parkinson’s disease drug candidate successful

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

Amgen announces results of Phase 3 trial in the treatment of bone metastases

Amgen announces results of Phase 3 trial in the treatment of bone metastases

Medtronic to showcase cardiovascular product portfolio at TCT 2009

Medtronic to showcase cardiovascular product portfolio at TCT 2009

Positron to promote its Attrius cardiac optimized PET scanner at the MedAxiom Fall Conference

Positron to promote its Attrius cardiac optimized PET scanner at the MedAxiom Fall Conference

Millennium's sNDA for VELCADE granted priority review by the FDA

Millennium's sNDA for VELCADE granted priority review by the FDA

EPO and growth factor therapy safe for anemic MDS patients

EPO and growth factor therapy safe for anemic MDS patients

Results from the BLOSSOM trial announced by Arena Pharmaceuticals

Results from the BLOSSOM trial announced by Arena Pharmaceuticals

Drug carrier that cuts off blood supply to tumors

Drug carrier that cuts off blood supply to tumors

4D Medical Systems launches the 4D PhotoStation System in the U.S.

4D Medical Systems launches the 4D PhotoStation System in the U.S.

Nimotuzumab drug approved for Mexican distribution

Nimotuzumab drug approved for Mexican distribution

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.